Viemed Healthcare Stock Earnings Per Share
| VMD Stock | USD 6.32 0.25 4.12% |
Fundamental analysis of Viemed Healthcare allows traders to better anticipate movements in Viemed Healthcare's stock price by examining its financial health and performance throughout various phases of its business cycle.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Viemed Healthcare Company Earnings Per Share Analysis
Viemed Healthcare's Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Current Viemed Healthcare Earnings Per Share | 0.31 X |
Most of Viemed Healthcare's fundamental indicators, such as Earnings Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Viemed Healthcare is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
| Competition |
According to the company disclosure, Viemed Healthcare has an Earnings Per Share of 0.31 times. This is 96.3% lower than that of the Health Care Equipment & Supplies sector and notably higher than that of the Health Care industry. The earnings per share for all United States stocks is 90.06% higher than that of the company.
Viemed Earnings Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Viemed Healthcare's direct or indirect competition against its Earnings Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Viemed Healthcare could also be used in its relative valuation, which is a method of valuing Viemed Healthcare by comparing valuation metrics of similar companies.Viemed Healthcare is currently under evaluation in earnings per share category among its peers.
Viemed Fundamentals
| Return On Equity | 0.0989 | ||||
| Return On Asset | 0.0611 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 230.98 M | ||||
| Shares Outstanding | 39.52 M | ||||
| Shares Owned By Insiders | 12.96 % | ||||
| Shares Owned By Institutions | 65.60 % | ||||
| Number Of Shares Shorted | 405.83 K | ||||
| Price To Earning | 29.88 X | ||||
| Price To Book | 1.74 X | ||||
| Price To Sales | 1.03 X | ||||
| Revenue | 224.26 M | ||||
| Gross Profit | 136.68 M | ||||
| EBITDA | 42.31 M | ||||
| Net Income | 11.41 M | ||||
| Cash And Equivalents | 21.92 M | ||||
| Cash Per Share | 0.57 X | ||||
| Total Debt | 6.87 M | ||||
| Debt To Equity | 0.06 % | ||||
| Current Ratio | 2.34 X | ||||
| Book Value Per Share | 3.41 X | ||||
| Cash Flow From Operations | 39.09 M | ||||
| Short Ratio | 1.95 X | ||||
| Earnings Per Share | 0.31 X | ||||
| Target Price | 11.75 | ||||
| Number Of Employees | 1.22 K | ||||
| Beta | 1.34 | ||||
| Market Capitalization | 239.91 M | ||||
| Total Asset | 177.07 M | ||||
| Retained Earnings | 89.69 M | ||||
| Working Capital | 15.55 M | ||||
| Net Asset | 177.07 M |
About Viemed Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Viemed Healthcare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Viemed Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Viemed Healthcare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Viemed Healthcare is a strong investment it is important to analyze Viemed Healthcare's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Viemed Healthcare's future performance. For an informed investment choice regarding Viemed Stock, refer to the following important reports:Check out Viemed Healthcare Piotroski F Score and Viemed Healthcare Altman Z Score analysis. For information on how to trade Viemed Stock refer to our How to Trade Viemed Stock guide.You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Is Healthcare space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Viemed Healthcare. If investors know Viemed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Viemed Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Viemed Healthcare is measured differently than its book value, which is the value of Viemed that is recorded on the company's balance sheet. Investors also form their own opinion of Viemed Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Viemed Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Viemed Healthcare's market value can be influenced by many factors that don't directly affect Viemed Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Viemed Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Viemed Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Viemed Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.